Mydecine’s new patent application may lead to a way to derive the medicinal benefits of psilocybin at lower doses.

The mental healthcare industry is ripe for innovation.  And companies like Mind Cure (CSE: MCUR), which recently completed its IPO, are set to lead the way.

This is Mind Cure’s third high-profile addition to its Scientific Advisory Board in the last week.

Publicly traded multistate marijuana operators appear to be in better financial health than they were at the beginning of the year, but many have shed operations in potentially lucrative markets to bolster their balance sheets.

Mind Cure adds a thought leader in the psychedelics space to its Advisory Board.

A recreational cannabis market in Montana could generate sales of more than $200 million in its first year of operation in 2022, according to a new study from the University of Montana’s Bureau of Business and Economic Research.

After more than a year of delays due to logistical errors and allegations of impropriety, the state has picked 11 companies to expand and diversify Maryland’s medical cannabis industry.

A campaign working to pass a ballot measure to decriminalize all drugs in Oregon just got a significant financial boost from a foundation run by Facebook founder and CEO Mark Zuckerberg and his wife.

Field Trip will make its trading debut on Tuesday.

Move over Big Pharma, Here Comes Silicon Valley Investment In Psychedelics Stocks Like Compass Pathways (CMPS)